PHARMACY AND POISONS REGULATIONS 2013 BR 35 / 2013
The Minister responsible for health, in exercise of the power conferred by section
48(1)(g) of the Pharmacy and Poisons Act 1979, makes the following Regulations:
Citation 1
These Regulations may be cited as the Pharmacy and Poisons Regulations 2013. Amends the Third Schedule to the Pharmacy and Poisons Act 1979 2
The Third Schedule to the Pharmacy and Poisons Act 1979 is amended in
paragraph 1 by inserting, in the appropriate alphabetical order, the following—
AcamprosateAcarboseAcitretinAdapaleneAdefovirAgomelatineAlendronateAlfuzosinAliskirenAlitretinoinAlmotriptanAmbrisentanAmlodipine
PHARMACY AND POISONS REGULATIONS 2013
AnagrelideAnastrozoleAprepitantAripiprazoleAtazanavirAtomoxetineAtorvastatinAtovaquoneAzelaic acidAzithromycinBalsalazideBenazeprilBetaxololBexaroteneBezafibrateBicalutamideBimatoprostBisoprololBosentanBrimonidineBrinzolamideBupropionBuspironeCabergolineCalcipotriolCalcium AcetateCandesartanCapecitabineCarvedilolCefdinirCefiximeCefpodoxime ProxetilCelecoxibCiclopiroxCilazaprilCinacalcetCiprofloxacin
PHARMACY AND POISONS REGULATIONS 2013
CitalopramClarithromycinClopidogrelClozapineColesevelamCrotamitonCyproheptadineDabigatranDarifenacinDasatinibDeferasiroxDeferiproneDesloratadineDesogestrelDidanosineDonepezil HydrochlorideDorzolamideDoxazosinDronedaroneDuloxetineDutasterideEfavirenzEflornithineEletriptanEltrombopagEmtricitabineEnalaprilEntacaponeEntecavirEpinastineEplerenoneErlotinibEscitalopramEsomeprazoleEstradiolEtravirineEverolimus
PHARMACY AND POISONS REGULATIONS 2013
ExemestaneExenatideEzetimibeFamciclovirFebuxostatFelodipineFenofibrateFesoterodineFexofenadineFinasterideFluconazoleFludarabineFluoxetineFlupentixolFlutamideFluticasoneFluvastatinFluvoxamineFormoterolFosinoprilFrovatriptanGabapentinGalantamineGefitinibGemfibrozilGlimepirideGlyburideGoserelinGranisetronHalobetasolIbandronateIdarubicinImatinibImiquimodIndinavirIndomethacinIrbesartan
PHARMACY AND POISONS REGULATIONS 2013
Isosorbide Mononitrate preparationsIsradipineIvabradineKetorolac TrometamolLacosamideLamivudineLamotrigineLansoprazoleLanthanumLapatinibLatanoprost
LeflunomideLetrozoleLeuprolideLevetiracetamLevocetirizineLevofloxacinLevothyroxineLinezolidLisinoprilLodoxamideLopinavirLosartanLoteprednol EtabonateMaravirocMefloquineMeloxicamMemantineMesalamineMethylergonovineMidodrineMifepristoneMirtazapineMisoprostolMoclobemideModafinil
PHARMACY AND POISONS REGULATIONS 2013
MoexiprilMometasoneMontelukastMoxifloxacinMupirocinMycophenolate MofetilNabumetoneNaltrexoneNaratriptanNateglinideNedocromilNelfinavirNepafenac
NevirapineNicardipineNilotinibNorfloxacinOfloxacinOlanzepineOlmesartanOlopatadine
OmeprazoleOndansetronOrlistatOseltamivirOxcarbazepinePaliperidonePancrelipasePantoprazoleParoxetinePazopanibPentosan Polysulfate SodiumPentoxifyllinePergolidePerindopril
PHARMACY AND POISONS REGULATIONS 2013
PimecrolimusPioglitazonePodophyllotoxinPosaconazolePramipexolePravastatinPregabalinProgesteronePropafenoneQuetiapineQuinagolideQuinaprilRabeprazoleRaloxifeneRaltegravirRamiprilRasagilineRepaglinideRiluzoleRimexoloneRisedronateRisperidoneRitonavirRivaroxabanRivastigmineRizatriptanRopiniroleRosiglitazoneRosuvastatinRotigotineRufinamideSalmeterolSandostatinSaquinavirSaxagliptinSertralineSevelamer Carbonate
PHARMACY AND POISONS REGULATIONS 2013
SildenafilSimvastatinSirolimusSitagliptinSolifenacinSorafenibStavudineSumatriptanSunitinibTacrolimusTadalafilTamsulosinTazaroteneTelithromycinTelmisartanTemozolomideTenofovirTerazosinThalidomideTiagabineTioguanine/ThioguanineTiotropiumTipranavirTizanidineTolcaponeTolterodineTopiramateTorasemideToremifeneTramadolTrandolaprilTravoprostTriamcinolone AcetonideTropicamideTrospiumValacyclovirValsartan
PHARMACY AND POISONS REGULATIONS 2013
VardenafilVareniclineVenlafaxineVigabatrinVoriconazoleZafirlukastZaleplonZidovudineZiprasidoneZolmitriptanZolpidemZonisamideZopiclone
Daily Market Report June 12, 2007 Highlights MACROECONOMY / FIXED INCOME / FOREX • Texas Instruments (-2% after hrs) said its Q2 U.S. Treasury yields were 2 bp higher on the long end with the short end unchanged after sales and profit won’t reach the high end of its Fed’s Pianalto said the economy remains strong and inflation is uncomfortably high. The 10yprevious es
COURTS’ STRUGGLE WITH INFERTILITY: THE IMPACT OF HALL V. NALCO ON INFERTILITY-RELATED EMPLOYMENT DISCRIMINATION This Note focuses on a recent Seventh Circuit case of first impression, Hall v. Nalco , which held that Title VII prohi- bits an employer from firing an employee for absenteeism re- lated to infertility treatments. Because Hall is the first cir- cuit co